A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections.

Congenic C5-deficient and C5-sufficient mice were infected with group B streptococci (GBS) to determine if the polymorphonuclear leukocyte (PMNL) chemoattractant C5a contributes to PMNL recruitment in GBS infection and if GBS C5a-ase reduces C5a-induced PMNL recruitment in vivo. PMNL accumulation was greater in the peritoneum and air spaces of C5-sufficient mice than in C5-deficient mice. Administration of human C5 to C5-deficient mice caused a significant increase in PMNL recruitment following infection with C5a-ase-negative GBS. GBS C5a-ase did not reduce PMNL accumulation in C5-sufficient mice but reduced PMNL recruitment in C5-deficient mice reconstituted with human C5. These data indicate that C5a is important for rapid PMNL recruitment to sites of GBS infection and that GBS C5a-ase inactivates human, but not murine, C5a in vivo. Reduction of the acute inflammatory response by C5a-ase likely contributes to GBS virulence in human neonates.

[1]  C. Baker.  Group B streptococcal infections. , 1997, Clinics in perinatology.

[2]  P. Ferrieri,et al.  Conservation of the C5a peptidase genes in group A and B streptococci , 1996, Infection and immunity.

[3]  P. Cleary,et al.  C5a peptidase alters clearance and trafficking of group A streptococci by infected mice , 1996, Infection and immunity.

[4]  C. Smith,et al.  Group B streptococci elicit leukotriene B4 and interleukin-8 from human monocytes: neonates exhibit a diminished response. , 1995, The Journal of infectious diseases.

[5]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[6]  O. Linderkamp,et al.  Complement Activation in Newborn Infants with Early Onset Infection , 1993, Pediatric Research.

[7]  H. Hill,et al.  Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species , 1993, Infection and immunity.

[8]  P. Barton,et al.  Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock , 1993, Infection and immunity.

[9]  A. Podbielski,et al.  Similarity between the group B and A streptococcal C5a peptidase genes , 1992, Infection and immunity.

[10]  C. Hammer,et al.  A rapid FPLC method for purification of the third component of human and guinea pig complement. , 1991, Journal of immunological methods.

[11]  H. Hill,et al.  Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. , 1991, The Biochemical journal.

[12]  F. Marches.  [Tumor necrosis factor or cachectin]. , 1991, Revue roumaine de virologie.

[13]  J. Berro,et al.  Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection. , 1990, The Journal of infectious diseases.

[14]  D. Haviland,et al.  Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon. , 1990, The Journal of biological chemistry.

[15]  T. Lint,et al.  Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5) , 1988, The Journal of experimental medicine.

[16]  H. Hill,et al.  Group B streptococci inhibit the chemotactic activity of the fifth component of complement. , 1988, Journal of immunology.

[17]  H. Hill.  Biochemical, Structural, and Functional Abnormalities of Polymorphonuclear Leukocytes in the Neonate , 1987, Pediatric Research.

[18]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[19]  G. Larsen,et al.  Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia. , 1984, The Journal of clinical investigation.

[20]  G. Toews,et al.  The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae. , 1984, The American review of respiratory disease.

[21]  T. Hugli.  Structure and function of the anaphylatoxins. , 1984, Springer seminars in immunopathology.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  C. Baker,et al.  Impaired Chemotaxigenesis by Type III Group B Streptococci in Neonatal Sera: Relationship to Diminished Concentration of Specific Anticapsular Antibody and Abnormalities of Serum Complement , 1983, Pediatric Research.

[24]  R. Nelson,et al.  Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors , 1983, Infection and immunity.

[25]  G. Larsen,et al.  The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. , 1982, The American review of respiratory disease.

[26]  D. Kasper,et al.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. , 1982, Journal of immunology.

[27]  K. Boyer,et al.  Group B streptococcal infections. , 2002, Pediatrics in review.

[28]  P. Henson,et al.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.

[29]  H. Hill,et al.  Pneumonia in the neonate associated with group B streptococcal septicemia. , 1976, American journal of diseases of children.

[30]  G. Cassady,et al.  Group B beta-hemolytic streptococcal infection in the newborn. I. Early onset infection. , 1974, American journal of diseases of children.